JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M400969200 on August 10, 2004

J. Biol. Chem., Vol. 279, Issue 43, 44931-44937, October 22, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/43/44931    most recent
M400969200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, X.
Right arrow Articles by LeSage, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, X.
Right arrow Articles by LeSage, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Degradation of the Apical Sodium-dependent Bile Acid Transporter by the Ubiquitin-Proteasome Pathway in Cholangiocytes*

Xuefeng Xia, Marlon Roundtree, Afkhamossadat Merikhi, Xiaohui Lu, Shujun Shentu, and Gene LeSage{ddagger}

From the Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, University of Texas at Houston Medical School, Houston, Texas 70030

To attenuate injury during cholestasis, adaptive changes in bile acid transporter expression in the liver provide alternative bile acid excretory pathways. Apical sodium-dependent bile acid transporter (ASBT) (SLC10A2), only expressed in the liver on the cholangiocyte apical membrane, is rapidly regulated in response to inflammation and bile acids. Here, we studied the mechanisms controlling ASBT protein levels in cholangiocytes to determine whether ASBT expression is regulated by ubiquitination and disposal through the proteasome. Protein turnover assays demonstrated that ASBT is an unstable and short-lived protein. Treatment with MG-132, a proteasome inhibitor, causes time-dependent increased ASBT levels and increased intracellular accumulation of ASBT. In cells cotransfected with green fluorescent protein-tagged ASBT and hemagglutinin-tagged ubiquitin, we demonstrated coimmunoprecipitation and colocalization of ASBT and ubiquitin. Interleukin-1{beta} (IL-1{beta}) induced down-regulation of ASBT is abrogated by a JNK inhibitor and is accompanied by an increase in ASBT polyubiquitin conjugates and a reduced ASBT half-life. In phosphorylation-deficient S335A and T339A mutants, the ASBT half-life is markedly prolonged, IL-1{beta}-induced ASBT ubiquitination is significantly reduced, and IL-1{beta} fails to increase ASBT turnover. These results indicate that ASBT undergoes ubiquitin-proteasome degradation under basal conditions and that ASBT proteasome disposal is increased by IL-1{beta} due to JNK-regulated serine/threonine phosphorylation of ASBT protein at both Ser-335 and Thr-339. These studies are the first report of regulation of a bile acid transporter expression by the ubiquitin-proteasome pathway.


Received for publication, January 28, 2004 , and in revised form, August 9, 2004.

* This work was supported by Grant NIDDK RO1 DK 54208 from the NIDDK National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Division of Gastroenterology, Hepatology and Nutrition, Dept. of Internal Medicine, University of Texas at Houston Medical School, 6431 Fannin, MSB 4.234, Houston, TX 770030. Tel.: 713-500-6677; Fax: 713-500-6699; E-mail: Gene.LeSage{at}uth.tmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Smith, X. Su, R. El-Maghrabi, P. D. Stahl, and N. A. Abumrad
Opposite Regulation of CD36 Ubiquitination by Fatty Acids and Insulin: EFFECTS ON FATTY ACID UPTAKE
J. Biol. Chem., May 16, 2008; 283(20): 13578 - 13585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
M. Miranda and A. Sorkin
Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms
Mol. Interv., June 1, 2007; 7(3): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hatanaka, Y. Hatanaka, and M. Setou
Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2
J. Biol. Chem., November 24, 2006; 281(47): 35922 - 35930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-Q. Sun, N. Balasubramaniyan, H. Chen, M. Shahid, and F. J. Suchy
Identification of Functionally Relevant Residues of the Rat Ileal Apical Sodium-dependent Bile Acid Cotransporter
J. Biol. Chem., June 16, 2006; 281(24): 16410 - 16418.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.